Patents by Inventor Angelo Guglielmotti

Angelo Guglielmotti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090186922
    Abstract: A 2-arylindole compound substituted in position 5, of formula (I): in which X, Y, Z, W, A, R and R? have the meanings given in the description, a pharmaceutical composition comprising it, and also intermediate compounds and a preparation process therefor.
    Type: Application
    Filed: June 14, 2007
    Publication date: July 23, 2009
    Applicant: AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.p.A.
    Inventors: Maria Alessandra Alisi, Nicola Cazzolla, Barbara Garofalo, Guido Furlotti, Caterina Maugeri, Rosella Ombrato, Isabella Coletta, Lorenzo Polenzani, Giorgina Mangano, Beatrice Garrone, Angelo Guglielmotti
  • Publication number: 20090054461
    Abstract: Use of a 1-(3-chlorophenyl)-3-alkylpiperazine of formula (I), in racemic (R, S) form or in the form of the (S) enantiomer, in which R is a linear or branched alkyl group having from 1 to 3 carbon atoms, or of an addition salt thereof with a pharmaceutically acceptable organic or inorganic acid, for treating apetite disorder A pharmaceutical composition that comprises a therapeutically effective amount of a 1-(3-chlorophenyl)-3-alkylpiperazine of formula (I) as previously defined or of an addition salt thereof with a pharmaceutically acceptable organic or inorganic acid, and at least one pharmaceutically acceptable excipient.
    Type: Application
    Filed: June 2, 2006
    Publication date: February 26, 2009
    Applicant: AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.P.A.
    Inventors: Beatrice Garrone, Maurizio Magnani, Guido Furlotti, Nicola Cazzolla, Angelo Guglielmotti
  • Publication number: 20070010555
    Abstract: An indazole having analgesic activity, a method for the preparation thereof and a pharmaceutical composition containing the same; the indazole has the following general formula: where X, Ra, Rb, Rc and Rd have the meanings stated in the description.
    Type: Application
    Filed: April 23, 2004
    Publication date: January 11, 2007
    Applicant: AZIENDE CHIM. RUIN. ANGEL. FRA. A.C.R.A.F. S.p.A.
    Inventors: Maria Alisi, Nicola Cazzolla, Guido Furlotti, Angelo Guglielmotti, Lorenzo Polenzani
  • Publication number: 20060211691
    Abstract: Use of a compound of formula (I), wherein R is H, a linear or branched alkyl chain having from 1 to 12 carbon atoms or an arylalkyl group, and of the acid addition salts thereof with pharmaceutically acceptable organic or inorganic acids, to prepare a pharmaceutical composition active in the treatment of neuropathic pain.
    Type: Application
    Filed: July 8, 2004
    Publication date: September 21, 2006
    Applicant: AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.P.A.
    Inventors: Angelo Guglielmotti, Lorenzo Polenzani, Alessandra Alisi, Nicola Cazzolla
  • Publication number: 20060183775
    Abstract: Use of a compound of formula (I), wherein X is CH or N, and when X is CH, R is H, OH, a linear or branched alkyl chain having from 1 to 3 carbon atoms, a linear or branched alkoxy chain having from 1 to 3 carbon atoms, or a halogen atom, and when X is N, R is H, or an acid addition salt thereof with a pharmaceutically acceptable organic or inorganic acid, to prepare a pharmaceutical composition active in the treatment of neuropathic pain.
    Type: Application
    Filed: July 8, 2004
    Publication date: August 17, 2006
    Applicant: Aziende Chimiche Riunite Angelini Francesco S.P.A.
    Inventors: Angelo Guglielmotti, Lorenzo Polenzani, Alessandra Alisi, Nicola Cazzolla
  • Patent number: 6534534
    Abstract: The present application relates to a method of treating atherosclerosis by administering to a patient a compound of formula: and/or salts thereof with pharmaceutically acceptable organic or inorganic bases.
    Type: Grant
    Filed: April 27, 2000
    Date of Patent: March 18, 2003
    Assignee: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
    Inventors: Angelo Guglielmotti, Alberto Mantovani
  • Patent number: 6191158
    Abstract: Use of a compound having formula (I) and salts thereof with pharmaceutically acceptable organic or inorganic bases, for preparing a pharmaceutical composition active in the treatment of disorders characterized by production of MCP-1 protein.
    Type: Grant
    Filed: April 25, 2000
    Date of Patent: February 20, 2001
    Assignee: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
    Inventors: Angelo Guglielmotti, Claudio Milanese
  • Patent number: 6020356
    Abstract: A pharmaceutical composition comprising an anti-inflammatory drug capable of suppressing the production of cytokines (CSAID) an immunosuppressant and a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: September 3, 1998
    Date of Patent: February 1, 2000
    Assignee: Angelini Ricerche S.p.A. Societa' Consortile
    Inventors: Angelo Guglielmotti, Paolo Dionisio